_on_a_T-cell_is_binding_to_a_molecule_on_a_cancer_-_Alpha_Tauri_3D_Graphics_M1_dc8762afeaee4937ad644739f274c7a5-620x480.jpg "Scientists aim to understand why T cells do not sustain energy in tumors")
Scientists aim to understand why T cells do not sustain energy in tumors
T cells are often called "assassins" or "killers" because they can orchestrate and carry out missions to hunt down bacteria, ...
Tag: Chimeric Antigen Receptor
Innovative CAR T cell therapy targets two proteins to combat aggressive brain tumor growth
In a recent report published in Nature Medicine, researchers presented the initial results of recurrent glioblastoma (rGBM) patients treated with ...
City of Hope cures oldest person of blood cancer and achieves HIV remission
City of Hope®, one of the largest cancer research and treatment organizations in the United States, treated the oldest person ...
CAR T cells target senescent cells, improve healthspan in mice
Chimeric antigen receptor (CAR) T cells have transformed the treatment of blood cancers in recent years. And there have been positive ...
St. Jude scientists discover potential CAR T cell therapy target for brain and solid tumors
Findings from St. Jude Children's Research Hospital are moving the field of cancer immunotherapy one step closer to treating brain ...
Phase III ZUMA-7 trial: Patients with high-risk large B-cell lymphoma lived longer with axi-cel
Patients with early relapsed or refractory large B-cell lymphoma had significantly improved overall survival when treated with the chimeric antigen ...
CAR T-cell therapy produces impressive results in first clinical trial in patients with multiple myeloma
A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced ...
Improving the immune defenses against blood cancer
For patients with lymphoma, multiple myeloma, or certain types of leukemia, treatment with chimeric antigen receptor T cells (CAR T ...
Preclinical study unlocks the promise of CAR T-cell therapy for treatment of solid tumors
Scientists at St. Jude Children's Research Hospital identified a molecular mechanism that in a preclinical study unlocked the promise of ...
POPULAR NEWS
